Tert-butyl N-methyl-N-[2-[[5-[4-(pyrazin-2-ylamino)quinolin-7-yl]pyrimidin-2-yl]amino]ethyl]carbamate
C25H28N8O2 — CID 155530423
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-methyl-N-[2-[[5-[4-(pyrazin-2-ylamino)quinolin-7-yl]pyrimidin-2-yl]amino]ethyl]carbamate
Tert-butyl N-methyl-N-[2-[[5-[4-(pyrazin-2-ylamino)quinolin-7-yl]pyrimidin-2-yl]amino]ethyl]carbamate (PubChem CID 155530423) has the molecular formula C25H28N8O2 and a molecular weight of 472.55 g/mol. Its IUPAC name is tert-butyl N-methyl-N-[2-[[5-[4-(pyrazin-2-ylamino)quinolin-7-yl]pyrimidin-2-yl]amino]ethyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-methyl-N-[2-[[5-[4-(pyrazin-2-ylamino)quinolin-7-yl]pyrimidin-2-yl]amino]ethyl]carbamate |
|---|---|
| PubChem CID | 155530423 |
| Molecular Formula | C25H28N8O2 |
| Molecular Weight | 472.55 g/mol |
| Exact Mass | 472.23 |
| IUPAC Name | tert-butyl N-methyl-N-[2-[[5-[4-(pyrazin-2-ylamino)quinolin-7-yl]pyrimidin-2-yl]amino]ethyl]carbamate |
| SMILES | CN(CCNc1ncc(-c2ccc3c(Nc4cnccn4)ccnc3c2)cn1)C(=O)OC(C)(C)C |
| InChI | InChI=1S/C25H28N8O2/c1-25(2,3)35-24(34)33(4)12-11-29-23-30-14-18(15-31-23)17-5-6-19-20(7-8-27-21(19)13-17)32-22-16-26-9-10-28-22/h5-10,13-16H,11-12H2,1-4H3,(H,27,28,32)(H,29,30,31) |
| InChIKey | QYVXDVMEBZRUJT-UHFFFAOYSA-N |
| XLogP | 4.50 |
| TPSA | 118.05 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 472.55 |
| LogP ≤ 5 | 4.50 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155530423 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.